Products Resources产品中心
CONTACT US
-
400 179 0116
24-hour service hotline
Products Description
RKO is a poorly differentiated colon carcinoma cell line developed by Michael Brattain. RKO cells contain wild-type p53 but lack endogenous human thyroid receptor nuclear receptor (h-TRbeta1).
